Avante At Mt Dora, Inc Medicare and Medicaid Location: 3050 Brown Ave, Mount Dora, Florida 32757 Ratings: Phone: (352) 383-4161 |
Edgewater At Waterman Village Medicare and Medicaid Location: 300 Brookfield Ave, Mount Dora, Florida 32757 Ratings: Phone: (352) 383-0051 |
News Archive
Researchers found that neutralizing antibodies against SARS-CoV-2 can increase over time. They observed that samples taken from convalescent plasma in September 2020 would likely have high enough values by July 2021 to protect immunodeficient patients who receive intravenous immunoglobulins as part of their treatment.
The American College of Occupational and Environmental Medicine today published new medical treatment guidelines for providing care to workers with injuries and disorders of the hip and groin. The new guidelines, which represent the latest chapter in ACOEM's comprehensive publication Occupational Medicine Practice Guidelines, are available on line now via ACOEM's APG-I web application; a print version will be available in the fall of 2010, when the Third Edition hard-copy of Occupational Medicine Practice Guidelines is published.
"Did McAllen get a bum rap? McAllen, Texas, spends more on Medicare patients than almost any other part of the country. A June 2009 New Yorker article by Atul Gawande attributed the high spending to a culture of doctors that 'came to treat patients the way sub-prime mortgage lenders treated home buyers: as profit centers.' The article became required reading in the White House and Congress during the health care debate and turned McAllen into shorthand for America's decadent medical spending problem."
Researchers report that performing angioplasty (a treatment that involves temporarily inserting and blowing up a tiny balloon inside a clogged artery to help widen it) on veins in the neck and chest is safeāand may be an effective way to treat the venous abnormalities found in those with multiple sclerosis and provide symptom relief.
Benitec Biopharma is pleased to announce the launch of a new exploratory cellular therapy program including exosome-based delivery utilising the Company's proprietary ddRNAi technology. Entry into these areas have been facilitated by the commencement of a collaboration with UK-based stem cell therapeutics company, ReNeuron.
› Verified 7 days ago